|Articles|January 3, 2022
Pharmacy Clinical Pearl of the Day: Gaucher Disease
Author(s)Saro Arakelians, PharmD
Symptoms of Gaucher disease include abdominal complaints, skeletal abnormalities, and blood disorders.
Advertisement
Clinical Pearl of the Day:Gaucher’s disease
Gaucher disease is the result of a buildup of certain fatty substances in certain organs, particularly the spleen and liver.
Insight:
- The fatty substances also can build up in bone tissue, weakening the bone and increasing the risk of fractures.
- If the bone marrow is affected, it can interfere with the blood's ability to clot.
- Symptoms include abdominal complaints, skeletal abnormalities, and blood disorders.
- Causes include hereditary history in the parents of the patient.
- Risk factors include Eastern and Central European Jewish ancestry.
- Diagnosis includes physical exam, lab tests, and imaging studies.
- Treatment includes enzyme replacement therapies, miglustat (Zavesca), eliglustat (Cerdelga), and osteoporosis drugs.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5